WeVote
Log In

Bill

Bill

HB 2965

covered entities; 340B drugs; distribution

57th Legislature - Second Regular Session Introduced by Chris Lopez

HB 2965 establishes state oversight rules for how Arizona hospitals and health systems distribute discounted drugs obtained through the federal 340B program.

House Second Reading
0
WeVote Research Nonpartisan
Bill Summary · HB 2965

Legislative bill overview

HB 2965 regulates how covered entities—primarily hospitals and health systems—can distribute and manage drugs obtained through the 340B Drug Pricing Program, which provides discounted medications to safety-net providers. The bill appears to establish rules around the acquisition, storage, and dispensation of these discounted drugs to ensure compliance with federal 340B program requirements and prevent diversion or misuse.

Why is this important

The 340B program saves covered entities hundreds of millions annually on prescription drugs, allowing them to reinvest savings into patient care, particularly for uninsured and underinsured populations. However, the program has faced scrutiny over allegations that some entities improperly profit from discounts rather than passing savings to patients, making oversight legislation directly relevant to program integrity and public trust.

Potential points of contention

  • Definition and scope of "covered entities": Disagreement over which hospitals/health systems qualify and whether the bill's restrictions apply equally to all entity types
  • Operational burden vs. oversight: Whether compliance requirements create excessive administrative costs that offset drug savings or appropriately prevent program abuse
  • Federal vs. state authority: Tension between state-level regulation and federal 340B program rules, potentially creating conflicting obligations for participating entities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.